Revenue
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cosmos Health Inc. (COSM)
Price$0.3542Cached quote
Net income
2010
2011
2012
2012
2013
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2014
2015
2016
2017
2018
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2010
2011
2012
2012
2013
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 · Dec 31 | 2013 · Jul 31 | 2012 · Dec 31 | 2012 · Jul 31 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.3M | $54.4M | $53.4M | $50.3M | $56.2M | $55.4M | $39.7M | $37.1M | $30.0M | $6.8M | $533,802 | $7.6M | $902,369 | — | — | — | — | — |
| Gross profit | $7.9M | $4.3M | $4.3M | $6.0M | $8.3M | $8.1M | $3.7M | $2.4M | $2.0M | $601,040 | $48,993 | $7.6M | — | — | — | — | — | — |
| Gross margin | 12.10% | 7.92% | 8.15% | 11.83% | 14.81% | 14.55% | 9.23% | 6.50% | 6.52% | 8.90% | 9.18% | 100.00% | — | — | — | — | — | — |
| Research & development | $519,363 | $533,293 | $164,859 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $24.6M | $19.9M | $26.2M | $13.4M | $12.9M | $5.3M | $3.9M | $3.6M | $6.8M | $803,547 | $491,452 | $523,305 | — | — | — | — | — | — |
| Operating income | −$16.7M | −$15.5M | −$21.8M | −$7.5M | −$4.5M | $2.7M | −$255,809 | −$1.2M | −$4.9M | −$202,507 | −$442,459 | $7.1M | $288,712 | −$344,543 | −$455 | −$330,589 | −$169,245 | — |
| Operating margin | −25.59% | −28.56% | −40.90% | −14.84% | −8.06% | 4.90% | −0.64% | −3.31% | −16.23% | −3.00% | −82.89% | 93.15% | 31.99% | — | — | — | — | — |
| EBITDA | −$15.3M | −$14.3M | −$21.2M | −$7.4M | −$4.2M | $3.1M | $138,819 | −$1.2M | −$4.8M | −$193,059 | −$437,043 | $7.1M | — | — | — | — | — | — |
| EBITDA margin | −23.51% | −26.32% | −39.75% | −14.64% | −7.43% | 5.62% | 0.35% | −3.19% | −16.15% | −2.86% | −81.87% | 93.27% | — | — | — | — | — | — |
| Net income | −$19.1M | −$16.2M | −$18.5M | −$13.8M | −$8.0M | $820,786 | −$3.3M | −$9.1M | −$6.2M | −$601,002 | −$6.7M | $6.0M | $246,592 | −$344,543 | −$455 | −$330,589 | −$169,245 | −$3.8M |
| Net profit margin | −29.33% | −29.73% | −34.74% | −27.47% | −14.16% | 1.48% | −8.31% | −24.43% | −20.69% | −8.90% | −1,252.88% | 79.13% | 27.33% | — | — | — | — | — |
| Basic EPSper basic share | -$0.63 | -$1.17 | -$2.15 | -$33.16 | -$23.74 | $1.50 | -$6.25 | -$17.00 | -$12.25 | $0.00 | -$12.50 | $12.50 | $0.00 | -$2.50 | $0.00 | -$2.50 | -$2.50 | — |
| Diluted EPSper diluted share | -$0.63 | -$1.17 | -$2.15 | -$33.16 | -$23.74 | $1.50 | -$6.25 | -$17.00 | -$12.25 | $0.00 | -$12.50 | $12.50 | $0.00 | -$2.50 | $0.00 | -$2.50 | -$2.50 | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Siokas Grigorios | 13.48M |
Terzis Georgios | 2.24M |
UBS Group AG | 594.46K |
VANGUARD FIDUCIARY TRUST CO | 333.84K |
JANE STREET GROUP, LLC | 289.29K |
GEODE CAPITAL MANAGEMENT, LLC | 282.09K |
BlackRock, Inc. | 267.8K |
VANGUARD CAPITAL MANAGEMENT LLC | 173.97K |
Aslidis Anastasios | 100K |
Bhutawala Suhel | 65K |
Demetriades Demetrios G. | 55K |
NORTHERN TRUST CORP | 53.89K |
Hoidas John James | 50K |
STATE STREET CORP | 45.24K |
Bardakis Nikolaos | 45K |
Sassicaia Capital Advisers LLC | 36K |
Karkantzos Theodoros Christos | 35K |
Ziegler Manfred | 20K |
KESTRA PRIVATE WEALTH SERVICES, LLC | 13K |
SIMPLEX TRADING, LLC | 7.14K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 16, 2026Form 4 | Terzis GeorgiosChief Financial Officer | BuyCommon Stock, par value $.001 | 168.1K | $0.25 | $42.0K | 2.24M |
| Jun 11, 2026Form 4 | Siokas GrigoriosChief Executive Officer | BuyCommon Stock, par value $.001 | 218.4K | $0.21 | $45.9K | 13.48M |
| Jun 10, 2026Form 4 | Siokas GrigoriosChief Executive Officer | BuyCommon Stock, par value $.001 | 701.4K | $0.23 | $161.3K | 13.26M |
| Feb 12, 2026Form 4 | Siokas GrigoriosChief Executive Officer | BuyCommon Stock, par value $.001 | 388.5K | $0.37 | $143.8K | 8.86M |
| Feb 11, 2026Form 4 | Siokas GrigoriosChief Executive Officer | BuyCommon Stock, par value $.001 | 291.3K | $0.41 | $119.4K | 8.47M |